RXO ($RXO) posted quarterly earnings results for Q4 2025 on Friday, February 6th. The company reported earnings of -$0.07 per share, missing estimates of -$0.04 by $0.03. The company also reported revenue of $1,469,000,000, missing estimates of $1,502,005,279 by $-33,005,279.
You can see Quiver Quantitative's $RXO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
RXO Insider Trading Activity
RXO insiders have traded $RXO stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- JASON S. KERR (Chief Accounting Officer) sold 33,343 shares for an estimated $385,778
- THOMAS A SZLOSEK purchased 20,308 shares for an estimated $251,209
- ANDREW M. WILKERSON (Chief Executive Officer) has made 2 purchases buying 11,625 shares for an estimated $149,422 and 0 sales.
- ADRIAN KINGSHOTT purchased 9,350 shares for an estimated $100,512
- TROY A. COOPER purchased 8,317 shares for an estimated $88,243
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RXO Hedge Fund Activity
We have seen 133 institutional investors add shares of RXO stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FINEPOINT CAPITAL LP added 7,266,839 shares (+inf%) to their portfolio in Q3 2025, for an estimated $111,763,983
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,302,185 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,407,605
- BLACKROCK, INC. added 1,761,129 shares (+8.0%) to their portfolio in Q3 2025, for an estimated $27,086,164
- LOOMIS SAYLES & CO L P removed 1,307,867 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $20,114,994
- ORBIS ALLAN GRAY LTD added 1,197,937 shares (+3.8%) to their portfolio in Q3 2025, for an estimated $18,424,271
- FRANKLIN RESOURCES INC added 1,110,530 shares (+91.2%) to their portfolio in Q3 2025, for an estimated $17,079,951
- RIVULET CAPITAL, LLC removed 995,750 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $15,314,635
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RXO Analyst Ratings
Wall Street analysts have issued reports on $RXO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/15/2026
- Morgan Stanley issued a "Overweight" rating on 11/11/2025
- Susquehanna issued a "Negative" rating on 11/07/2025
- Barclays issued a "Overweight" rating on 11/07/2025
To track analyst ratings and price targets for RXO, check out Quiver Quantitative's $RXO forecast page.
RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 10 analysts offer price targets for $RXO in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Lucas Servera from Truist Securities set a target price of $18.0 on 01/15/2026
- Jason Seidl from TD Cowen set a target price of $14.0 on 01/09/2026
- Ariel Rosa from Citigroup set a target price of $15.0 on 01/08/2026
- Bascome Majors from Susquehanna set a target price of $11.0 on 01/08/2026
- J. Bruce Chan from Stifel set a target price of $16.0 on 12/16/2025
- Ravi Shanker from Morgan Stanley set a target price of $19.0 on 11/11/2025
- Thomas Wadewitz from UBS set a target price of $15.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
